The Haiti NTD Control Program (HNTDCP) is a joint effort between the Ministry of Health and Population (MSPP) and the Ministry of Education (MENFP) to eliminate LF and control STH infection. In addition, IMA has been working closely with the HNTDCP to build its capacity to implement mass drug administration (MDA) and conduct monitoring and evaluation of program activities. IMA leads collaboration with the HNTDCP for MDA of diethylcarbamazine (DEC) and albendazole to prevent LF and control STH, respectively. IMA support has helped the HNTDCP move closer to its goal of LF elimination by 2020.
MDA is conducted through community distribution posts and schools, utilizing a network of approximately 20,000 trained community leaders, promoters, and drug distributors annually to educate the population and distribute drugs. IMA treats 5,1 million Haitians annually.